DermasilkRx SDS Pak and Metformin and repaglinide
Determining the interaction of DermasilkRx SDS Pak and Metformin and repaglinide and the possibility of their joint administration.
In the database of official manuals used in the service creation an interaction registered by statistical results of studies was found, which can either lead to negative consequences for the patient health or strengthen a mutual positive effect. A doctor should be consulted to address the issue of joint drug administration.
Consumer:Using metFORMIN together with repaglinide can increase the risk of hypoglycemia, or low blood sugar. You may need a dose adjustment or more frequent monitoring of your blood sugar to safely use both medications. Let your doctor know if you experience hypoglycemia during treatment. Symptoms of hypoglycemia include headache, dizziness, drowsiness, nervousness, confusion, tremor, nausea, hunger, weakness, perspiration, palpitation, and rapid heartbeat. It is important to tell your doctor about all other medications you use, including vitamins and herbs. Do not stop using any medications without first talking to your doctor.
Professional:MONITOR: Coadministration of metformin with an insulin secretagogue (e.g., sulfonylurea, meglitinide) or insulin may potentiate the risk of hypoglycemia. Although metformin alone generally does not cause hypoglycemia under normal circumstances of use, the added therapeutic effect when combined with other antidiabetic agents may result in hypoglycemia. The risk is further increased when caloric intake is deficient or when strenuous exercise is not compensated by caloric supplementation.
MANAGEMENT: A lower dosage of the insulin secretagogue or insulin may be required when used with metformin. Blood glucose should be closely monitored, and patients should be educated on the potential signs and symptoms of hypoglycemia (e.g., headache, dizziness, drowsiness, nervousness, confusion, tremor, hunger, weakness, perspiration, palpitation, tachycardia) and appropriate remedial actions to take if it occurs. Patients should also be advised to take precautions to avoid hypoglycemia while driving or operating hazardous machinery.
- Wiernsperger N, Rapin JR "Metformin-insulin interactions: from organ to cell." Diabetes Metab Rev 11 Suppl (1995): s3-12
- Okada S, Ishii K, Hamada H, Tanokuchi S, Ichiki K, Ota Z "Can alpha-glucosidase inhibitors reduce the insulin dosage administered to patients with non-insulin-dependent diabetes mellitus?" J Int Med Res 23 (1995): 487-91
Generic Name: triamcinolone topical
Brand name: DermasilkRx SDS Pak, Dermasorb TA, DermaWerx SDS Pak, Kenalog, Oralone, Trianex, Triderm, Aristocort A, Triacet, Aricin, Aristocort R, Delta-Tritex, Flutex, Rx Triamcinolone, Aristocort Topical, Cinalog, Cinolar, Kenalog in Orabase, Triamcinolone Acetonide in Absorbase, Pediaderm TA, DermacinRx SilaPak
Synonyms: Triamcinolone topical, Triamcinolone (Topical)
Generic Name: metformin / repaglinide
Brand name: PrandiMet
Synonyms: Repaglinide and Metformin
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- DermasilkRx SDS Pak-Metformin and saxagliptin
- DermasilkRx SDS Pak-Metformin and sitagliptin
- DermasilkRx SDS Pak-Metformin Extended-Release Tablets
- DermasilkRx SDS Pak-Metformin Hydrochloride
- DermasilkRx SDS Pak-Metformin Oral Solution
- DermasilkRx SDS Pak-Metformin Tablets
- Metformin and repaglinide-Dermasorb AF
- Metformin and repaglinide-Dermasorb AF Complete Kit Topical
- Metformin and repaglinide-Dermasorb HC
- Metformin and repaglinide-Dermasorb HC Complete Kit
- Metformin and repaglinide-Dermasorb TA
- Metformin and repaglinide-Dermasorb TA Complete Kit